Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-05-29 to 2025-05-30
Current total value of award: $421.24
Description: 4568384459!HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML